Warren C Fiskus

Instructor

  • 4695 Citations
  • 39 h-Index
19992019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 9 Similar Profiles
Histone Deacetylase Inhibitors Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
HSP90 Heat-Shock Proteins Medicine & Life Sciences
Apoptosis Medicine & Life Sciences
Leukemia Medicine & Life Sciences
Proteins Medicine & Life Sciences
Mantle-Cell Lymphoma Medicine & Life Sciences
Myeloid Cells Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2019

Leukemia, Myelomonocytic, Chronic
Myelodysplastic Syndromes
Diploidy
Cytogenetics
Survival
2 Citations (Scopus)

Superior efficacy of cotreatment with BET protein inhibitor and BCL2 or MCL1 inhibitor against AML blast progenitor cells

Fiskus, W. C., Cai, T., DiNardo, C., Kornblau, S. M., Borthakur, G., Kadia, T. M., Pemmaraju, N., Bose, P., Masarova, L., Rajapakshe, K., Perera, D., Coarfa, C., Mill, C. P., Saenz, D. T., Saenz, D. N., Sun, B., Khoury, J., Shen, Y., Konopleva, M. & Bhalla, K., Feb 1 2019, In : Blood cancer journal. 9, 2, 4.

Research output: Contribution to journalArticle

Proto-Oncogene Proteins c-bcl-2
Stem Cells
Apoptosis
Chromatin
Proteins
17 Citations (Scopus)

BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against mantle cell lymphoma cells

Sun, B., Fiskus, W. C., Qian, Y., Rajapakshe, K., Raina, K., Coleman, K. G., Crew, A. P., Shen, A., Saenz, D. T., Mill, C. P., Nowak, A. J., Jain, N., Zhang, L., Wang, L., Khoury, J., Coarfa, C., Crews, C. M. & Bhalla, K., Feb 1 2018, In : Leukemia. 32, 2, p. 343-352 10 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Protein Transport
Proteolysis
Apoptosis
Ubiquitin-Protein Ligases

Targeting nuclear β-catenin as therapy for post-myeloproliferative neoplasm secondary AML

Saenz, D. T., Fiskus, W. C., Manshouri, T., Mill, C. P., Qian, Y., Raina, K., Rajapakshe, K., Coarfa, C., Soldi, R., Bose, P., Borthakur, G., Kadia, T. M., Khoury, J., Masarova, L., Nowak, A. J., Sun, B., Saenz, D. N., Kornblau, S. M., Horrigan, S., Sharma, S. & 4 othersQiu, P., Crews, C. M., Verstovsek, S. & Bhalla, K., Jan 1 2018, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Catenins
Stem Cells
Neoplasms
Therapeutics
Apoptosis
21 Citations (Scopus)

BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells

Saenz, D. T., Fiskus, W. C., Manshouri, T., Rajapakshe, K., Krieger, S., Sun, B., Mill, C. P., DiNardo, C., Pemmaraju, N., Kadia, T. M., Parmar, S., Sharma, S., Coarfa, C., Qiu, P., Verstovsek, S. & Bhalla, K., Mar 1 2017, In : Leukemia. 31, 3, p. 678-687 10 p.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
Myeloid Cells
HSP90 Heat-Shock Proteins
Neoplasms
Proteins